OA12257A - the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals. - Google Patents

the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals. Download PDF

Info

Publication number
OA12257A
OA12257A OA1200200332A OA1200200332A OA12257A OA 12257 A OA12257 A OA 12257A OA 1200200332 A OA1200200332 A OA 1200200332A OA 1200200332 A OA1200200332 A OA 1200200332A OA 12257 A OA12257 A OA 12257A
Authority
OA
OAPI
Prior art keywords
acid
infection
présent
per
mixture
Prior art date
Application number
OA1200200332A
Other languages
English (en)
Inventor
Wayne Alan Boettner
Peter Connor Canning
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA12257A publication Critical patent/OA12257A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
OA1200200332A 2000-04-27 2001-03-26 the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals. OA12257A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19996100P 2000-04-27 2000-04-27

Publications (1)

Publication Number Publication Date
OA12257A true OA12257A (en) 2003-11-06

Family

ID=22739732

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200332A OA12257A (en) 2000-04-27 2001-03-26 the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals.

Country Status (30)

Country Link
US (2) US20020019353A1 (es)
EP (1) EP1276747A1 (es)
JP (1) JP2004516233A (es)
KR (1) KR20030031479A (es)
CN (1) CN1227258C (es)
AP (1) AP2002002652A0 (es)
AR (1) AR028041A1 (es)
AU (1) AU4269301A (es)
BG (1) BG107168A (es)
BR (1) BR0110382A (es)
CA (1) CA2407448A1 (es)
CZ (1) CZ20023409A3 (es)
EA (1) EA200200995A1 (es)
GT (1) GT200100063A (es)
HU (1) HUP0300585A3 (es)
IL (1) IL152421A0 (es)
IS (1) IS6559A (es)
MA (1) MA26896A1 (es)
MX (1) MXPA02010586A (es)
NO (1) NO20025134L (es)
OA (1) OA12257A (es)
PA (1) PA8515601A1 (es)
PE (1) PE20011188A1 (es)
PL (1) PL359861A1 (es)
SK (1) SK14882002A3 (es)
TN (1) TNSN01063A1 (es)
UY (1) UY26678A1 (es)
WO (1) WO2001081358A1 (es)
YU (1) YU78702A (es)
ZA (1) ZA200208603B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003040782A (ja) * 2001-05-31 2003-02-13 Pfizer Prod Inc アザリド抗生物質組成物
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
WO2009117036A2 (en) * 2007-12-21 2009-09-24 Massachusetts Institute Of Technology Bioactive molecules from co-cultivation of microbes
AU2013280331C1 (en) * 2012-06-27 2018-06-21 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
US10568923B2 (en) * 2012-06-27 2020-02-25 Kemin Industries, Inc. Plant parts and extracts having anticoccidial activity
RU2763296C2 (ru) 2016-12-15 2021-12-28 Сосьете Де Продюи Нестле С.А. Композиции и способы, которые регулируют бактерии у животного-компаньона
CN106905396A (zh) * 2017-02-21 2017-06-30 西南大学 富马酸替米考星复盐的制备方法
CN106905395A (zh) * 2017-02-21 2017-06-30 西南大学 丁二酸替米考星复盐的制备方法
CN106749458A (zh) * 2017-02-21 2017-05-31 西南大学 苹果酸替米考星复盐的制备方法
JP7100652B2 (ja) * 2017-02-22 2022-07-13 アイエスアール イミューン システム レギュレイション ホールディング アクチエボラグ(パブル) 新規免疫刺激マクロライド
MX2021005423A (es) * 2018-11-19 2021-09-08 Zikani Therapeutics Inc Macrolidos de 13 miembros sustituidos con c10-alquileno y usos de los mismos.
CN109535211B (zh) * 2018-12-19 2020-05-08 江苏威凌生化科技有限公司 一种合成纯化泰拉霉素杂质c的方法
KR20240056746A (ko) * 2021-09-07 2024-04-30 조에티스 서비시즈 엘엘씨 면역조정성 아잘라이드

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
SK14882002A3 (en) 2004-11-03
HUP0300585A3 (en) 2003-09-29
GT200100063A (es) 2002-02-18
IL152421A0 (en) 2003-05-29
ZA200208603B (en) 2003-10-24
UY26678A1 (es) 2001-12-28
CN1227258C (zh) 2005-11-16
US20020019353A1 (en) 2002-02-14
MXPA02010586A (es) 2003-03-10
NO20025134D0 (no) 2002-10-25
AP2002002652A0 (en) 2002-12-31
TNSN01063A1 (fr) 2005-11-10
NO20025134L (no) 2002-12-19
HUP0300585A2 (hu) 2003-06-28
EA200200995A1 (ru) 2003-04-24
BG107168A (bg) 2003-07-31
CZ20023409A3 (cs) 2004-01-14
BR0110382A (pt) 2003-06-24
EP1276747A1 (en) 2003-01-22
JP2004516233A (ja) 2004-06-03
CA2407448A1 (en) 2001-11-01
PE20011188A1 (es) 2001-11-24
CN1429232A (zh) 2003-07-09
IS6559A (is) 2002-09-20
PA8515601A1 (es) 2002-07-30
AU4269301A (en) 2001-11-07
YU78702A (sh) 2005-11-28
PL359861A1 (en) 2004-09-06
WO2001081358A1 (en) 2001-11-01
KR20030031479A (ko) 2003-04-21
AR028041A1 (es) 2003-04-23
MA26896A1 (fr) 2004-12-20
US20040235759A1 (en) 2004-11-25

Similar Documents

Publication Publication Date Title
EP1250343B1 (en) Azalide antibiotic compositions
RU2478643C2 (ru) Макроциклические полиморфы, композиции, содержащие такие полиморфы, и способы их применения и получения
OA12257A (en) the use of azalide antibiotic compositions for treating or preventing a bacterial or protozoal infection in mammals.
EP1262186B1 (en) Azalide antibiotic compositions
US20030171307A1 (en) Azalide antibiotic compositions
US10485812B2 (en) Stable antibacterial composition